Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Ophthalmology | Pharmacy | Geriatrics | News

Back to Health News

Statins Tied to Reduced Glaucoma Risk

Last Updated: October 02, 2012.

 

Large study found possible preventive effect against blindness-causing eye condition

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Large study found possible preventive effect against blindness-causing eye condition.

By Amanda Gardner
HealthDay Reporter

TUESDAY, Oct. 2 (HealthDay News) -- Researchers may have discovered yet another potential use for the widely used cholesterol-lowering drugs known as statins.

In a new study, older people with high cholesterol who had taken statins for two years had an 8 percent reduced risk of developing open-angle glaucoma, the most common form of the eye disease.

"That's a big deal," said Dr. Mark Fromer, an ophthalmologist at Lenox Hill Hospital in New York City, and eye surgeon director for the New York Rangers hockey team. "We're talking 3 million people [in the United States] who have glaucoma and half those people don't know it."

Fromer was not involved with the study, which appears in the October issue of Ophthalmology.

Glaucoma, which often affects people over 60, can lead to blindness. People at higher risk include those with a family member with glaucoma, blacks and older Hispanics, according to the Glaucoma Research Foundation.

Originally developed to treat high cholesterol, statins such as Lipitor (atorvastatin) and Zocor (simvastatin) have been studied for their possible benefits in a number of other conditions, including central nervous system disorders such as ischemic stroke, Alzheimer's and multiple sclerosis.

"There's growing evidence that statins may be beneficial beyond their cholesterol-lowering properties," said study lead author Dr. Joshua Stein, an assistant professor of ophthalmology and visual sciences at the University of Michigan Kellogg Eye Center in Ann Arbor.

An earlier study by Stein's team had found that people with metabolic syndrome -- a cluster of symptoms linked to diabetes and heart disease -- who had high cholesterol as one of their defining symptoms had a decreased risk of glaucoma compared to those who didn't have high cholesterol as part of the syndrome.

In this new study, the researchers set out to determine if it was the high cholesterol or treatment for the high cholesterol that might be behind the decreased glaucoma risk.

A review of medical records of more than 500,000 Americans over the age of 60 with high cholesterol found that those taking statins had a 0.3 percent decreased risk of developing glaucoma for every month they took statins.

Those who took statins continually for one year had a 4 percent to 5 percent reduced risk compared to people not taking statins.

The likelihood of actually developing glaucoma in people with risk factors for the condition was also decreased, as was the risk of requiring some kind of treatment for the condition, suggesting that the earlier people take statins the greater the apparent benefit.

People on non-statin cholesterol-lowering medications, on the other hand, didn't have a reduced risk of glaucoma, suggesting "there's something special about statins beyond just their cholesterol-lowering properties," Stein said.

Statins' effect on the central nervous system is a potential mechanism for the finding, the researchers suggested, as glaucoma affects both the optic nerve and the retinal nerve fibers. Statins also increase the activity of an enzyme that affects blood flow, possibly resulting in improved blood flow to the eye.

Or statins might be decreasing eye pressure, a major risk factor for glaucoma, the researchers suggested.

The trial, however, was not designed to determine a cause-and-effect relationship between statins and glaucoma, so all that can be said at this point is that there's a link.

Nor is it yet known if the medications might stave off glaucoma in people without high cholesterol, meaning the findings aren't enough to recommend taking statins just to reduce the risk of glaucoma.

But they do suggest that people taking these medications to lower their cholesterol may be gaining an added, unexpected benefit, the authors say.

More information

The Glaucoma Research Foundation has more on this condition.

SOURCES: Joshua D. Stein, M.D., assistant professor of ophthalmology and visual sciences, University of Michigan Kellogg Eye Center, Ann Arbor, Mich.; Mark Fromer, M.D., ophthalmologist, Lenox Hill Hospital, New York City and eye surgeon director, New York Rangers; October 2012, Ophthalmology

Copyright © 2012 HealthDay. All rights reserved.


Previous: Diabetes Patients Should Have More Voice in Treatment: Experts Next: New Autism Criteria Will Have Minor Impact: Study

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.